~~<i id='C6D1E4090F'><strike id='C6D1E4090F'><tt id='C6D1E4090F'><pre id='C6D1E4090F'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

knowledge

author：Wikipedia 2025-08-12 08:26:09 - browse：337

Calling Bullshit course University of Washington — Screenshot via callingbullshit.org

Tired of alternative facts, fake news, and breathless hyperbole, two professors at the University of Washington are trying to strike a blow for science.

Their weapon? A new course: “Calling Bullshit In the Age of Big Data.”

The class website and colorful syllabus went online last month and almost instantly went viral.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Readout Newsletter: BridgeBio, Akero, and human embryo models

hotspot

explore

focus

leisure time

AlisonSbranaattheNIHClinicalCenterinBethesda,Md.,participatesinastudyonmyalgicencephalomyelitis/chro

WSS

Ozempic has benefits for kidney disease as well as diabetes

Readout Newsletter: BridgeBio, Akero, and human embryo models

Obesity drugs seen as possible treatment for liver disease MASH

The public health thinking behind the CDC’s new Covid guidance

$1 billion proposal to grow Boston, Massachusetts biotech

Biden's 'march

focus

knowledge

hotspot

After affirmative action ruling, medical educators look to 'holistic review'

Ozempic has benefits for kidney disease as well as diabetes

What does generative AI mean for health care? We asked experts

The public health thinking behind the CDC’s new Covid guidance

Continuity nursing helped my family in our darkest PICU moments

Change Healthcare: What is it, why does its cyberattack matter?

Activists slam private health insurers over coverage restrictions

Medicare drug price negotiation continues, as pharma counteroffers

Dobbs anniversary: the lost opportunity of abortion as health care

Why Talkspace is targeting Medicare, a tricky market

hotspot

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

Dario to buy mental health app maker Twill in cash and stock deal

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Why Talkspace is targeting Medicare, a tricky market

Biden's 'march

hotspot

explore

focus

leisure time